Actavis CEO Says Health Law May Boost Generics Use

Feb. 15 (Bloomberg) -- Paul Bisaro, chief executive officer of Actavis Inc., talks about the impact of the U.S. Affordable Care Act on the pharmaceutical industry, so-called biosimilars, generic versions of biotechnology drugs, and the outlook for growth. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
Equity Valuations Lofty, Earnings Lousy: Morganlander
25:54 - Stifel Nicolaus' Chad Morganlander and Bloomberg's Michael Regan discuss the global selloff in stocks with Bloomberg's Pimm Fox on "Taking Stock." (Source: Bloomberg)
  • `Time Is of the Essence' for Greece to Reach Deal: Lew
  • A Penthouse Perspective on NYC Real Estate
  • Will the Comcast-Time Warner Cable Merger Ever Happen?